study
-
Spine
BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
— Collaboration follows recent manufacturing/clinical process enhancements that have tripled monthly trial capacity — — Patient enrollment expected to be…
Read More » -
Spine
Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up
Groundbreaking ReActiv8-B study supports the long-term efficacy, safety and durability of ReActiv8® Restorative NeurostimulationTM for the treatment of intractable Chronic Low…
Read More » -
Recon
Exactech Presented New Research Showcasing Its AI Technologies at the 2024 Orthopaedic Research Society Annual Meeting
GAINESVILLE, Fla., Feb. 22, 2024 /PRNewswire/ — Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery,…
Read More » -
Hospitals
HSS Study Reveals Concerning Link Between Growth Hormone Therapy and Growth Plate Fractures in Children
Parents and Physicians Should Discuss this Potential Complication of Growth Hormone Treatment for Active Children and Adolescents NEW YORK, Jan. 4,…
Read More » -
Recon
Stronger Thigh Muscles May Prevent Knee Replacement Surgery
CHICAGO, Nov. 27, 2023 /PRNewswire/ — Stronger quadriceps muscles, relative to the hamstrings, may lower the risk of total knee replacement, according…
Read More » -
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, presented five-year…
Read More » -
Biologics
Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98.6% Spine Fusion Rates in Patients Treated With i-FACTOR®
WESTMINSTER, Colo., Oct. 17, 2023 /PRNewswire/ — Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone…
Read More » -
Biologics
U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA
ATLANTA, Oct. 4, 2023 /PRNewswire/ — The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study…
Read More » -
Extremities
Loci Orthopaedics Announces Completion of Patient Enrollment for Its Clinical Feasibility Study of Its “InDx” Thumb Base Joint Replacement
GALWAY, Ireland, October 3, 2023–(BUSINESS WIRE)–Loci Orthopaedics announced today that it has successfully completed enrollment of a 15-patient clinical feasibility…
Read More »